openPR Logo
Press release

According to Latest Research Study Global Biomarkers Market expected to grow at a CAGR of 12.2% and would reach USD 78.9 billion by 2024

09-27-2017 08:27 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Biomarkers Market

Global Biomarkers Market

Global Biomarkers Market is expected to USD 78.9 billion by 2024, from USD 31.4 billion in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Brief Sample of the Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market

Factors that led to growth in the Global Biomarkers Market are increase in research and development financing and in drugs discovery along with the spending more in healthcare activities. The developing use of biomarkers in medical areas (cancer treatment) and new players entrants will definitely lead to the growth of biomarkers market in future. Biomarkers are widely used to distinguish diseases such as, cancer, cardiovascular disorders, neurological disorders, immunological disorders and many others. In the field of oncology, as of late three natural markers have been added to breast cancer disease risk models to distinguish ladies at a higher danger.

Major Market Drivers and Restraints:

• Increase in R&D financing and healthcare expenditure
• Developing number of CROs
• Rising utility of biomarkers for treatment purposes
• Ease in leading clinical trials in developing countries
• High capital ventures and cost-to-profit proportions
• High cost of testing, sample collection, and storage
• Administrative and reimbursement challenges

The market is segmented on the basis of type, technology, application, indication, and geography.

Read more about the report @ http://databridgemarketresearch.com/reports/global-biomarkers-market/
Based On Type:
• Consumables
• Services
• Softwares
Based on Technology:
• Efficacy
• Safety
• Validation Biomakers
Based On Application:
• Diagnostics
• Drug Discovery
• Personalized Medicine
• Disease Risk Assessment
Based On Indication:
• Cancer
• Cardiovascular Disorders
• Immunological Disorders

Request for TOC: http://databridgemarketresearch.com/toc/?dbmr=global-biomarkers-market

Based on geography the market is segmented into 5 major countries such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

The Global Biomarkers Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Some of the major players operating in this market are
• QIAGEN
• PerkinElmer, Inc.
• Merck & Co.
• Bio-Rad Laboratories Inc.
• Enzo Biochem Inc.
• EKF Diagnostics Holdings Plc
• Abbott
• Siemens AG
• MESO SCALE DIAGOSTICS, LLC
• Agilent Technologies
• Singulex, Inc.
• Cisbio Bioassays
• Thermo Fisher Scientific Inc.
• Bruker
• Biosims Technologies
• Epigenomics AG
• Signosis, Inc.
• GE Healthcare

Speak to our Analyst: http:/databridgemarketresearch.com/speak-to-analyst/?dbmr=global-biomarkers-market

Table Of Content:

1.INTRODUCTION

1.1.OVERVIEW OF THE GLOBAL BIOMARKERS MARKET

1.2.MARKET SEGMENTATION & COVERAGE

1.2.1.CURRENCY AND PRICING

1.2.2.LIMITATION

1.2.3.STAKEHOLDERS

2.RESEARCH METHODOLOGY

2.1.KEY TAKEAWAYS

2.2.ARRIVING AT THE GLOBAL BIOMARKERS MARKET SIZE

2.2.1.MARKET CRACKDOWN APPROACH

2.2.2.COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3.DATA TRIANGULATION

2.2.4.KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5.PRODUCT PIPELINE ANALYSIS

2.2.6.PORTER’S FIVE FORCES MATRIX

2.3.GLOBAL BIOMARKERS MARKET: RESEARCH SNAPSHOT

2.4.ASSUMPTIONS

3.MARKET LANDSCAPE SUMMARY

4.PREMIUM INSIGHTS

4.1.OVERVIEW

4.2.GLOBAL BIOMARKERS MARKET: KEY PRIMARY INSIGHTS

4.3.MARKET OVERVIEW

4.3.1.DRIVERS

4.3.1.1.INCREASING HEALTHCARE EXPENDITURE

4.3.1.2.NON-INVASIVE

4.3.1.3.LOW-COST FOR CONDUCTING CLINICAL TRIALS

4.3.1.4.GROWING NUMBER OF CROs

4.3.2.RESTRAINTS

4.3.3.OPPURTUNITIES

4.3.4.THREATS

4.4.KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5.EXECUTIVE SUMMARY

6.BIOMARKERS MARKET, BY PRODUCT TYPE

6.1.OVERVIEW

6.2.CONSUMABLES,

6.3.SERVICES,

6.4.SOFTWARE,

7.BIOMARKERS MARKET, BY TECHNOLOGY

7.1.OVERVIEW

7.2.SAFETY BIOMARKERS

7.3.EFFICACY BIOMARKERS

7.4.VALIDATION BIOMARKERS

8.BIOMARKERS MARKET, BY APPLICATION

8.1. OVERVIEW

8.2. DIAGNOSTICS DEVELOPMENT

8.3. DRUG DISCOVERY AND DEVELOPMENT

8.4. PERSONALIZED MEDICINE

8.5 DISEASE-RISK ASSESSMENT

8.6. OTHERS

9.BIOMARKERS MARKET, BY INDICATION

9.1.OVERVIEW

9.2.CANCER

9.3.CARDIOVASCULAR DISORDERS

9.4.NEUROLOGICAL DISORDERS

9.5.IMMUNOLOGICAL DISORDERS

9.6.OTHER DISEASES

10.BIOMARKERS MARKET, BY GEOGRAPHY

10.1.COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

10.1.1.NORTH AMERICA

10.1.1.1.U.S.

10.1.1.2.CANADA

10.1.1.3.MEXICO

10.1.2.EUROPE

10.1.2.1.GERMANY

10.1.2.2.FRANCE

10.1.2.3.U.K.

10.1.2.4.ITALY

10.1.2.5.SPAIN

10.1.2.6.RUSSIA

10.1.2.7.TURKEY

10.1.2.8.BELGIUM

10.1.2.9.NETHERLANDS

10.1.2.10.SWITZERLAND

10.1.2.11.REST OF EUROPE

10.1.3.ASIA-PACIFIC (APAC)

10.1.3.1.JAPAN

10.1.3.2.CHINA

10.1.3.3.SOUTH KOREA

10.1.3.4.INDIA

10.1.3.5.AUSTRALIA

10.1.3.6.SINGAPORE

10.1.3.7.THAILAND

10.1.3.8.MALAYSIA

10.1.3.9.INDONESIA

10.1.3.10.PHILIPPINES

10.1.3.11.REST OF APAC

10.1.4.LATIN AMERICA

10.1.4.1.BRAZIL

10.1.4.2.REST OF LATIN AMERICA

10.1.5.MIDDLE EAST AND AFRICA

10.1.5.1.SOUTH AFRICA

10.1.5.2.REST OF MIDDLE EAST AND AFRICA

10.2.KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11.BIOMARKERS MARKET: COMPETITIVE LANDSCAPE

11.1.GLOBAL BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.2.U.S. BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.3.EUROPE BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.4.APAC BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.5.SOUTH AMERICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.6.MIDDLE EAST AND AFRICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.7.MERGERS & ACQUISITIONS

11.8.NEW PRODUCT DEVELOPMENT & APPROVALS

11.9.EXPANSIONS

11.10.REGULATORY CHANGES

11.11.PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12.BIOMARKERS MARKET, COMPANY PROFILES

12.1.QIAGEN N.V

12.1.1.COMPANY OVERVIEW

12.1.2.SWOT ANALYSIS

12.1.3.REVENUE ANALYSIS

12.1.4.PRODUCT PORTFOLIO

12.1.5.RECENT DEVELOPEMENTS

12.1.6.DATA BRIDGE ANALYSIS

12.2.PERKINELMER, INC

12.2.1.COMPANY OVERVIEW

12.2.2.SWOT ANALYSIS

12.2.3.REVENUE ANALYSIS

12.2.4.PRODUCT PORTFOLIO

12.2.5.RECENT DEVELOPEMENTS

12.2.6.DATA BRIDGE ANALYSIS

12.3.MERCK & CO, INC.

12.3.1.COMPANY OVERVIEW

12.3.2.SWOT ANALYSIS

12.3.3.REVENUE ANALYSIS

12.3.4.PRODUCT PORTFOLIO

12.3.5.RECENT DEVELOPEMENTS

12.3.6.DATA BRIDGE ANALYSIS

12.4.BIO-RAD LABORATORIES

12.4.1.COMPANY OVERVIEW

12.4.2.SWOT ANALYSIS

12.4.3.REVENUE ANALYSIS

12.4.4.PRODUCT PORTFOLIO

12.4.5.RECENT DEVELOPEMENTS

12.4.6.DATA BRIDGE ANALYSIS

12.5.ENZO BIOCHEM, INC.,

12.5.1.COMPANY OVERVIEW

12.5.2.SWOT ANALYSIS

12.5.3.REVENUE ANALYSIS

12.5.4.PRODUCT PORTFOLIO

12.5.5.RECENT DEVELOPEMENTS

12.5.6.DATA BRIDGE ANALYSIS

12.6.EKF DIAGNOSTICS HOLDINGS, PLC

12.6.1.COMPANY OVERVIEW

12.6.2.SWOT ANALYSIS

12.6.3.REVENUE ANALYSIS

12.6.4.PRODUCT PORTFOLIO

12.6.5.RECENT DEVELOPEMENTS

12.6.6.DATA BRIDGE ANALYSIS

12.7.MESO SCALE DIAGNOSTICS

12.7.1.COMPANY OVERVIEW

12.7.2.SWOT ANALYSIS

12.7.3.REVENUE ANALYSIS

12.7.4.PRODUCT PORTFOLIO

12.7.5.RECENT DEVELOPEMENTS

12.7.6.DATA BRIDGE ANALYSIS

12.8.LLC, SINGULEX, INC.,

12.8.1.COMPANY OVERVIEW

12.8.2.SWOT ANALYSIS

12.8.3.REVENUE ANALYSIS

12.8.4.PRODUCT PORTFOLIO

12.8.5.RECENT DEVELOPEMENTS

12.8.6.DATA BRIDGE ANALYSIS

12.9.CISBIO BIOASSAYS

12.9.1.COMPANY OVERVIEW

12.9.2.SWOT ANALYSIS

12.9.3.REVENUE ANALYSIS

12.9.4.PRODUCT PORTFOLIO

12.9.5.RECENT DEVELOPEMENTS

12.9.6.DATA BRIDGE ANALYSIS

12.10.BIOSIMS TECHNOLOGIES

12.10.1.COMPANY OVERVIEW

12.10.2.SWOT ANALYSIS

12.10.3.REVENUE ANALYSIS

12.10.4.PRODUCT PORTFOLIO

12.10.5.RECENT DEVELOPEMENTS

12.10.6.DATA BRIDGE ANALYSIS

12.11. SIGNOSIS, INC.

12.11.1.COMPANY OVERVIEW

12.11.2.SWOT ANALYSIS

12.11.3.REVENUE ANALYSIS

12.11.4.PRODUCT PORTFOLIO

12.11.5.RECENT DEVELOPEMENTS

12.11.6.DATA BRIDGE ANALYSIS

13.APPENDIX

14.ABOUT DATA BRIDGE MARKET RESEARCH

Other Report

Global Drug Delivery Devices Market – Trends and Forecast to 2024

Global Drug Delivery Devices Market, By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), End-User (Hospitals, Clinics, Home Care Settings), Distribution Channel (Direct Tenders,Hospital Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Trends and Forecast To 2024

Report Access: http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release According to Latest Research Study Global Biomarkers Market expected to grow at a CAGR of 12.2% and would reach USD 78.9 billion by 2024 here

News-ID: 744392 • Views:

More Releases from Data Bridge Market Research

Aquaculture Products Market Size, Share, Trends, Key Drivers, Growth Opportuniti …
Aquaculture Products Market business report provides a profound overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. The data and information collected to generate this top-notch market report has been derived from the trusted sources such as company websites, white papers, journals, and mergers etc. Aquaculture Products Market report includes basic, secondary and advanced information related to the global
Hydrochloric Acid Market Size, Share, Trends, Demand, Future Growth, Challenges …
Data Bridge Market research has recently released expansive research titled Global Hydrochloric Acid Market  guarantees you will remain better informed than your competition.The report is formulated based on the market type, organization size, availability on-premises, the end-users' organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Businesses can accomplish knowledge about complete background analysis of the industry which includes
Electrostatic Disinfectant Sprayer Market Size, Share, Demand, Future Growth, Ch …
Global Electrostatic Disinfectant Sprayer Market report puts light on analysis of prime manufacturers, trends, opportunities, marketing strategies analysis, market effect factor analysis and consumer needs by major regions, types, and applications globally. The study offers a comprehensive analysis of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments. The data and information covered in the Electrostatic Disinfectant Sprayer report are obtained from reliable sources
Paint Protection Film Market Size, Share, Trends, Opportunities, Key Drivers and …
Global Paint Protection Film Market study by Data Bridge Market Research provides details about the market dynamics affecting this market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. The latest market data has been presented in the Paint Protection Film market study on the revenue numbers, product details, and sales of the major firms. In addition

All 5 Releases


More Releases for BIOMARKERS

Predisposition Biomarkers Market - Rapid Growth at Deep Value Price from 2020-20 …
"The new report has been added by qyresearch.com to provide detailed insight into the global Predisposition Biomarkers market. The study will help to get a better understanding about the Predisposition Biomarkers industry competitors, a channel for the distribution, Predisposition Biomarkers growth potential, potentially disruptive trends, Predisposition Biomarkers industry product innovations, market size value/volume (regional/country level, Predisposition Biomarkers industry segments), market share of top players/products. Due to the pandemic, we have included
3rd World Biomarkers Summit
We cordially invite you to the 3rd World Biomarkers Summit to be held at Rome, Italy on April 22-23, 2020. The 2020 edition of the Biomarkers conference will move forward with the theme “Biomarker as a future protagonist”. Biomarkers 2020 concentrates on procuring emerging researches in the sector of medicine and health brought to us via applications of biomarkers. Scientists, Young researchers, pharmaceutical industrialists and medical professionals are expected to
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out